The Israeli Ministry of Health (IMH) has cleared a safety medical device and software application company, Revolutions Medical's RevVac safety syringe.
The RevVac auto retractable vacuum safety syringe utilizes a patented technology in which a vacuum causes the needle to retract into the barrel of the syringe or device after an injection is administered or blood is drawn.
As part of the approval, Revolutions’ Israeli distributor, Ceifit, can now accept and fulfill orders from the country’s four national medical centers.
Revolutions is also permitted to supply its syringes previously pledged to support the IMH’s Izhar project to combat the re-use of contaminated needles.
Revolutions Medical chief executive officer and chairman Ron Wheet said, "We are optimistic that, with this important license, we will be able to see rapid adoption of our product throughout the Israeli healthcare system."
Revolutions products include safety blood drawing device, the RevColor, RevDisplay and Rev3D software tools which are compatible with MRIs and picture archiving computer systems.